JY
OPRX icon

Jeff Yass’s OptimizeRx OPRX Stock Holding History

Jeff Yass’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-30,800
Closed -$193K – 14220
2026
Q1 		$193K Sell
30,800
-2,100
-6% -$19.5K ﹤0.01% 11743
2025
Q4 		$403K Sell
32,900
-10,800
-25% -$176K ﹤0.01% 9280
2025
Q3 		$896K Sell
43,700
-4,700
-10% -$74.6K ﹤0.01% 7599
2025
Q2 		$653K Buy
48,400
+30,800
+175% +$337K ﹤0.01% 8541
2025
Q1 		$152K Buy
+17,600
New +$108K ﹤0.01% 11218
2024
Q3 		– Sell
-58,000
Closed -$580K – 12739
2024
Q2 		$580K Buy
+58,000
New +$637K ﹤0.01% 7900
2024
Q1 		– Sell
-15,300
Closed -$219K – 13006
2023
Q4 		$219K Buy
+15,300
New +$147K ﹤0.01% 10487
2023
Q3 		– Sell
-160,800
Closed -$2.3M – 12685
2023
Q2 		$2.3M Sell
160,800
-1,900
-1% -$27.1K ﹤0.01% 4869
2023
Q1 		$2.38M Sell
162,700
-56,600
-26% -$947K ﹤0.01% 4788
2022
Q4 		$3.68M Buy
219,300
+51,400
+31% +$889K ﹤0.01% 3695
2022
Q3 		$2.49M Buy
167,900
+12,300
+8% +$243K ﹤0.01% 4472
2022
Q2 		$4.26M Buy
155,600
+136,900
+732% +$4.06M ﹤0.01% 3443
2022
Q1 		$705K Sell
18,700
-232,100
-93% -$10.3M ﹤0.01% 8063
2021
Q4 		$15.6M Sell
250,800
-3,200
-1% -$242K ﹤0.01% 2126
2021
Q3 		$21.7M Buy
254,000
+19,000
+8% +$1.19M ﹤0.01% 1889
2021
Q2 		$14.5M Sell
235,000
-28,800
-11% -$1.47M ﹤0.01% 2406
2021
Q1 		$12.9M Buy
263,800
+213,400
+423% +$10.3M ﹤0.01% 2411
2020
Q4 		$1.57M Buy
50,400
+5,200
+12% +$127K ﹤0.01% 5629
2020
Q3 		$942K Buy
+45,200
New +$776K ﹤0.01% 6258
2019
Q4 		– Sell
-17,200
Closed -$249K – 10373
2019
Q3 		$249K Buy
+17,200
New +$266K ﹤0.01% 8684

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Jeff Yass's OPRX Position: Q2 2026 in Review

Jeff Yass increased its OptimizeRx (OPRX) stake by 243% in Q2 2026, buying an estimated $159K and bringing the position to 39,003 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #11708.

Jeff Yass first reported a position in OPRX in Q4 2018 and has held it in 17 quarters since. The position peaked at $2.95M in Q1 2023. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Jeff Yass held 39,003 shares of OptimizeRx worth $223K as of Q2 2026.
  • Jeff Yass bought 27,630 OptimizeRx shares in Q2 2026, an estimated $159K.
  • OptimizeRx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #11708 holding.
  • Jeff Yass first reported a position in OptimizeRx in Q4 2018 and has held it in 17 quarters since.
  • Jeff Yass's OptimizeRx position peaked at $2.95M in Q1 2023.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.